Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Gross Margin (2020 - 2022)

Immuneering (IMRX) has 3 years of Gross Margin data on record, last reported at 100.0% in Q4 2022.

  • For Q4 2022, Gross Margin rose 10877.0% year-over-year to 100.0%; the TTM value through Sep 2023 reached 100.0%, up 7199.0%, while the annual FY2022 figure was 50.11%, 555.0% up from the prior year.
  • Gross Margin reached 100.0% in Q4 2022 per IMRX's latest filing, up from 49.6% in the prior quarter.
  • Across five years, Gross Margin topped out at 100.0% in Q4 2022 and bottomed at 8.77% in Q4 2021.
  • Average Gross Margin over 3 years is 49.56%, with a median of 50.55% recorded in 2022.
  • The widest YoY moves for Gross Margin: up 10877bps in 2022, down -496bps in 2022.
  • A 3-year view of Gross Margin shows it stood at 53.85% in 2020, then crashed by -116bps to 8.77% in 2021, then surged by 1240bps to 100.0% in 2022.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 100.0% in Q4 2022, 49.6% in Q3 2022, and 49.23% in Q2 2022.